Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTICIPATE: Dexrazoxane for Prevention of Anthracycline-Induced Cardiac Dysfunction in DLBCL
NCT06220032Phase 3Recruiting
- Sponsor
- HOVON
- Start
- Aug 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexrazoxane in cardiomyopathy, sponsored by HOVON. Started Aug 2024; status: recruiting.
02
Drugs
dexrazoxane
03
Conditions
cardiomyopathy
Beyond the preview
Go deeper on NCT06220032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06220032.